The funding round was led by backers including Episode 1 and the Google Black Founders Fund.
"Businesses and law firms now realise that with the right technology, tasks that used to require significant amounts of time and effort, can be largely completed in seconds. Our technology can summarise thousands of documents and extract the key points in a fraction of the time. It can read and edit legal documents with far less human effort and can give specific advice automatically. We have typically saved our clients around 70% of their costs related to contract review. Our technology is AI+, advanced machine learning combined with human expertise that enables our customers to focus on the more complex, strategic work they?re best at."
The seed round was backed by ACF Investors, o2h Ventures, and angel investors to fund team expansion and platform development.
"With this investment, our investors have affirmed the strength of our technology and its commercial potential. Building upon years of research, this funding will drive the development of our platform, facilitate the rollout of our own range of therapeutics and expand our team. As our recent collaboration with the UCL Drug Discovery Institute has shown, we are beginning to have a potent effect on the pharmaceutical industry and I am looking forward to the many ways in which we can make a decisive contribution to medicine worldwide"
The Series A round was led by 2150 with backing from Zigg Capital, Westerly Winds, and previous investors to expand the rollout of its infrastructure software.
Highland Europe leads a £13m Series A round in insurtech firm Hyperexponential to scale its engineering and commercial teams.
"The insurance industry is experiencing unprecedented growth, with data and technology being critical strategic drivers. Our software provides the tools that new entrants to the sector need in order to get to market with best-in-class analytics, and the functionality that incumbent insurers require in order to transform."
The pre-seed round was co-led by Kodori AG and Calm/Storm to support product expansion and team growth.
"Thymia was born when a close friend of mine tried to take her own life. Her friends and doctors missed the signs that she was so seriously unwell, not least because the process of accessing the right treatment was based on out-dated methodologies not fit for the complexities and nuances of an illness like depression."